책 이미지

eBook 미리보기
책 정보
· 제목 : Interventional Cardiology (Hardcover, 1st) 
· 분류 : 외국도서 > 의학 > 심장학
· ISBN : 9780071415279
· 쪽수 : 846쪽
· 출판일 : 2006-12-01
· 분류 : 외국도서 > 의학 > 심장학
· ISBN : 9780071415279
· 쪽수 : 846쪽
· 출판일 : 2006-12-01
목차
Contributors
Foreword
Preface
Acknowledgments
Part 1. Knowledge Foundation
Section 1. Anatomy for Interventional Cardiology
1.Coronary Artery Anatomy for the Interventionalist
2.Cardiac Chamber Anatomy
3.Peripheral Anatomy for the Interventionalist
Section 2. Physiology
4.The Coronary Circulation
5.Physiological Evaluation of Renal Artery Stenosis: A Hemodynamic Approach
Section 3. Pathophysiology
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Preface
Acknowledgments
Part 1. Knowledge Foundation
Section 1. Anatomy for Interventional Cardiology
1.Coronary Artery Anatomy for the Interventionalist
2.Cardiac Chamber Anatomy
3.Peripheral Anatomy for the Interventionalist
Section 2. Physiology
4.The Coronary Circulation
5.Physiological Evaluation of Renal Artery Stenosis: A Hemodynamic Approach
Section 3. Pathophysiology
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Section 1. Anatomy for Interventional Cardiology
1.Coronary Artery Anatomy for the Interventionalist
2.Cardiac Chamber Anatomy
3.Peripheral Anatomy for the Interventionalist
Section 2. Physiology
4.The Coronary Circulation
5.Physiological Evaluation of Renal Artery Stenosis: A Hemodynamic Approach
Section 3. Pathophysiology
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
2.Cardiac Chamber Anatomy
3.Peripheral Anatomy for the Interventionalist
Section 2. Physiology
4.The Coronary Circulation
5.Physiological Evaluation of Renal Artery Stenosis: A Hemodynamic Approach
Section 3. Pathophysiology
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
4.The Coronary Circulation
5.Physiological Evaluation of Renal Artery Stenosis: A Hemodynamic Approach
Section 3. Pathophysiology
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
6.Valvular Pathophysiology
7.Arterial Disease
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
8.Ventricular Pathophysiology
Part 2. Equipment: Construction and Performance
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
9.Equipment for Percutaneous Coronary Intervention
10.Design and Construction of Stents
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
11.Adjunctive Devices: Atherectomy, Thrombectomy, Embolic Protections, IUVS, Doppler, and Pressure Wires
Part 3. Principles and Catheter Laboratory Equipment
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
12.X-Ray Cinefluorographic Systems
13.Operational Radiation Management for Patients and Staff
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
14.General Principles of Coronary Artery Brachytherapy
15.X-Ray Computed Tomography and Magnetic Resonance Imaging of the Coronary Arteries
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
16.Intracardiac Echocardiography in the Catheterization Laboratory
17.Cardiac Catheterization Laboratory Physiologic Recorders
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
18.Digital Image Formats and Archiving Practices
Part 4. Pharmacology
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
19.Antithrombin Therapies
20.Antiplatelet Therapies in Contemporary Percutaneous Coronary Intervention
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
21.Thrombolytic Therapy
22.Radiographic Contrast Media
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
23.Renal Complications of Contrast Media
24.Patient Sedation in the Cardiovascular Catheterization Laboratory
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Part 5. Procedures
25.Diagnostic Procedures: Special Considerations
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
26.Diagnostic Procedures: Peripheral Angiography
27.Adjunctive Diagnostic Techniques
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
28.Coronary Guidewire Manipulation
29.Coronary Balloon Angioplasty
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
30.Coronary Stenting, Bare Metal Stents, and Drug-Eluting Stents
31.Rotational Atherectomy: Concepts and Practice
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
32.Brachytherapy
33.Basic Wire-Handling Strategies for Chronic Total Occlusion
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
34.Percutaneous Intervention in Chronic Total Coronary Occlusions
35.Directional Coronary Atherectomy
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
36.Distal Embolic Protection Devices
37.Intervention in Venous and Arterial Grafts
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
38.Special Considerations: Acute Myocardial Infarction
39.Complex Lesion Intervention: Bifurcation, Left Main Coronary Artery, and Ostial Lesions
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
40.Special Considerations: Small Vessel and Diffuse Disease
41.Special Patient Subsets: Diabetic and Elderly
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
42.Inoue-Balloon Mitral Valvuloplasty
43.Aortic Valvuloplasty and Future Solutions to Aortic Valve Disease
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
44.Balloon Pulmonary Valvuloplasty
45.Percutaneous Closure of Atrial Septal Defect and Patent Foramen Ovale
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
46.Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
47.Coronary Vein Device Insertion
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
48.Device Retrieval Systems
49.Percutaneous Treatment of Coronary Artery Fistulas
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
50.Renal Artery Angioplasty and Stenting
51.Iliac Angioplasty and Stenting
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
52.Endovascular Abdominal Aortic Aneurysm Repair
53.Carotid and Vertebral Artery Intervention
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Part 6. Complications and Management
54.Risk Stratification in Interventional Cardiology
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
55.Acute Threatened Coronary Closure
56.Subacute Closure
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
57.Coronary Artery Perforation
58.Embolization and No-Reflow During Percutaneous Coronary Intervention
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
59.Emergency Surgery
60.Complications of Peripheral Procedures
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Part 7. Medical Management of Risk Factors
61.Lipid-Lowering Therapy and the Interventional Cardiologist
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
62.Hypertension
63.Diabetes and Cardiovascular Disease
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
64.Nontraditional Risk Factors for Atherosclerosis
Part 8. Preclinical and Clinical Trials
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
65.Preclinical Laboratory Functions
66.The Core Laboratory: Quantitative Coronary Angiography and Intravascular Ultrasound
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
67.How to Read Clinical Trials
Part 9. Reimbursement and Hospital Finance
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
68.Cost-Effectiveness
69.Quality Assurance and Quality Improvement in Interventional Cardiology
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
Part 10. Principles of Innovation
70.Innovation and Interventional Cardiology: Looking Back, Thinking Ahead
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
71.Principles of Innovation: Transforming Clinical Needs into Viable Inventions
Index
추천도서
분야의 베스트셀러 >